Mynvax is an India-based pharmaceutical company that develops and commercializes novel recombinant vaccines for the treatment of COVID-19 and human influenza.
Business Model:
Revenue: $3M
Employees: 11-50
Address: Society for Innovation and Development
City: Bangalore
State: karnataka
Zip: 560012
Country: IN
Mynvax is an India-based pharmaceutical company that develops and commercializes novel recombinant vaccines for the treatment of COVID-19 and human influenza.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2018 | Angel | - | 8/2020 | Grant | $546.4k | 10/2018 | Angel Round | 1 | - |
Ajith Sukumaran Ajith Sukumaran |
7/2021 | Series A | $4.2M |
Accel LetsVenture 1Crowd Kotak Investment Advisors |
7/2021 | Series A | 4 | $4.1M |
1Crowd Accel Kotak Investment Advisors LetsVenture 1Crowd Accel Kotak Investment Advisors LetsVenture |
10/2020 | Pre-Series A | $2.5M |
1Crowd |
7/2018 | Angel | - | 10/2018 | Angel Round | 1 | - |
Ajith Sukumaran Ajith Sukumaran |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|